Your formula for success, where technology meets humanity
Approach
Digital health doesn’t struggle because of innovation.
It struggles because pharma is complex.
AMD-Advisory helps digital health and AI companies navigate the pharmaceutical ecosystem — aligning strategy, regulatory readiness, and commercial execution to unlock meaningful enterprise partnerships.
We turn ambition into traction.
Our Formulas
Go-to-Market
Strategy
Pharma doesn’t reward industry noise. It rewards precision.
We design commercial strategies that translate innovation into revenue — aligning positioning, stakeholders, and execution from day one.
Partnership
Building
Solid partnerships don’t happen by chance. They’re engineered.
We connect the right players, structure the right deals, and ensure alignment from pilot to scale.
Innovation
& Scaling
Innovation without operational rigor doesn’t scale.
We embed AI and optimize processes to drive measurable efficiency, improve outcomes, and enable enterprise-wide adoption.
Our Offers
Startup formula
Innovation alone doesn’t win pharma deals.
We help digital health founders become enterprise-ready — refining positioning, proving value, and unlocking strategic partnerships.
Enterprise formula
Pharma doesn’t need more pilots — it needs scalable digital impact.
We help enterprise teams identify, structure, and operationalize digital health partnerships that actually deliver.
Investor formula
Not all digital health scales in pharma.
We help investors separate signal from noise — validating commercial viability, regulatory readiness, and real-world adoption potential.
About
Aisling Murray is a digital health executive operating at the intersection of pharma, AI, and commercial strategy.
She has led global partnerships and growth initiatives at BrightInsight, Huma, Medisafe, and Revisto — helping scale digital platforms, structure enterprise deals, and implement AI-driven solutions within highly regulated environments.
As Founder of AMD-Advisory, Aisling works with digital health innovators and enterprise leaders to navigate pharmaceutical complexity, accelerate strategic partnerships, and scale responsibly.
With global leadership experience, an MBA from ESADE, and executive education from Columbia and MIT, she brings both strategic vision and operational rigor to companies building the future of healthcare.